2024 – 1st BELNUC Radioligand Therapy Course

1st BELNUC Radioligand Therapy Course

  • Address: Sheraton Brussels Airport, 1930 Brussel, Belgium
  • Date: November 30th, 2024

CLICK HERE TO REGISTER! (registration is open now!)

Early registration: until October 24th, 2024

Late registration: until November 22nd, 2024

Please be aware that you have to have a valid BELNUC membership for the year 2024 that has been paid before April 30th, 2024 to benefit from the reduced fee!

We are extremely pleased to extend a formal invitation to you to participate the inaugural BELNUC Radioligand Therapy Course! This premier event is scheduled for November 30th, 2024 at the Sheraton Brussels Airport, a venue in the heart of Belgium.

The 1st BELNUC Radioligand Therapy Course is poised to be a landmark gathering of multidisciplinary professionals and leading experts in radioligand therapy (RLT). Our goal is to facilitate a dynamic exchange of practical insights and best practices in RLT delivery, providing attendees with a clear pathway to expand the use of these treatments at their institution.

This event presents an unparalleled opportunity for networking and engaging with the nuclear medicine community. A unique feature of this course is the hands-on demonstrator sessions for (dosimetry) tools and equipment related to RLT.

Preliminary Program*

MAIN AUDITORIUM EXHIBITION/LUNCH ROOM
8:30-9:00 Registration

 
9:00 Welcome

 
9:00-9:30 Setting up an RLT service – Physician’s view (Prof. Dr. N. Withofs, CHU Liège)

 

 Exhibitor setup

 

 

 

 

 
9:30-10:00 Setting up an RLT service – Technologist’s view (TBD)

 
10:00-10:30 Setting up an RLT service – Physicist’s view (V. Nuttens PhD, OLV Aalst-Asse-Ninove)

 
10:30-11:00 Setting up an RLT service – Physicist’s view (V. Nuttens PhD, OLV Aalst-Asse-Ninove)

 

 10:30-11:15 Dosimetry/Equipment demonstrator session (with coffee break)

 

 

 

 
NET session (moderator: prof. Ch. Deroose)

11:00-11:15 Overview of the current treatment landscape and management of NET (TBD)
11:15-11:35 Pros and Cons of RLT in the management of (Prof. Dr. Ch. Verslype, UZ Leuven)

 
11:35-12:15 Challenges and controversies in NET RLT: Interactive case discussion

Panel:

  • Prof. Dr. Ch. Deroose (UZ Leuven)
  • Prof. Dr. Ch. Verslype (UZ Leuven)
  • Dr. I. Karfis (Institut Jules Bordet / HUB)

 
12:15-13:30

 

 Lunch + Exhibition

 
Prostate cancer session (moderator: dr. K. Muylle)

13:30-13:45 Overview of the current treatment landscape and management of mCRPC (Prof. Dr. Brieuc Sautois, CHU Liège)

 
13:45-14:05: Pros and Cons of RLT in the management of mCRPC (Dr. C. Artigas, Institut Jules Bordet/HUB)

 
14:05-15:00 Challenges and controversies in mCRPC RLT: Interactive case discussion

Panel:

  • Prof. Dr. N. Withofs (CHU Liège)
  • Prof. Dr. Brieuc Sautois (CHU Liège)
  • Dr. K. De Man (UZ Gent)
  • Dr. C. Artigas (Institut Jules Bordet / HUB)
15:00-15:45  15:00-16:15 Dosimetry/Equipment demonstrator session (with coffee break)

 

 

 
15:45-16:15: The RLT Center of Excellence framework (Dr. I. Karfis, Institut Jules Bordet/HUB)
16:15-17:00 Panel discussion – Overcoming the remaining hurdles in RLT: patient access, radioprotection, and reimbursement

Panel:

  • Prof. Dr. M. Koole (UZ Leuven)
  • Prof. dr. Z. Wimana (Institut Jules Bordet/HUB)
  • Dr. K. Muylle (AZ Delta Roeselare-Menen-Torhout/VUB)
  • Prof .Dr. Ch. Deroose (UZ Leuven)
  • Prof. Dr. N. Withofs (CHU Liège)
 Exhibitor cleanup

 

 

 

 

 

 

*Please note that this program is preliminary and may be changed without further notice.

The BELNUC RLT course has been accredited by FANC:

  • 3u00 voor Radiotherapeuten Open Bronnen
  • 5u30 voor Nuclearisten
  • 5u30 voor Stralingsfysicus NG
  • 5u30 voor Gemachtigden NG
  • 5u30 voor Radiofarmaceuten